Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
An article in today’s New York Times (“‘Cancer’ or ‘weird cells’: which sounds deadlier?“) focuses on the question of whether many conditions currently referred to as “cancer” really are … and whether by calling them “cancer” we prejudice doctors and patients into taking overly aggressive action.
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: breast, cancer, myeloma, name, prostate, risk | 9 Comments »
For those who like to know what is happening out on the farther reaches of cancer research, there is an interesting article by George Johnson in today’s New York Times.
Filed under: Uncategorized | Tagged: cancer, development, hypothesis | Leave a Comment »
Sometimes it is difficult to know what to make of data from even the most reputable institutions. This appears to be the case for a recent study from a Harvard research team.
Filed under: Living with Prostate Cancer | Tagged: cancer, cost, drug coverage, Medicare, non-adherence | Leave a Comment »
A commonly raised question is whether men with benign prostatic hyperplasia (BPH) are at greater risk for prostate cancer than men who have no sign of BPH. A new, nation-wide study of the male population of Denmark over the past 27 years offers us some insights.
Filed under: Diagnosis, Risk | Tagged: association, benign prostatic hyperplasia, BPH, cancer, Denmark, risk | Leave a Comment »
Under the “And this helps me how?” column we can now add the topic of a possible genetic link between endometrial cancer and prostate cancer (maybe).
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: cancer, endometrial, genome, SNP, womb | Leave a Comment »
According to a media release issued on Thursday this week, the National Business Group on Health has been working with the National Comprehensive Cancer Network (NCCN) to develop and now launch a major, 3-year-long initiative to help employers address issues of cancer in the workplace.
Filed under: Diagnosis, Living with Prostate Cancer, Prevention, Risk | Tagged: cancer, education, employee, employer, initiative | Leave a Comment »
The full text of a review entitled “Fruit and vegetables and cancer risk” is available on the web site of the British Journal of Cancer, and it is not good news.
Filed under: Diagnosis, Prevention, Risk | Tagged: cancer, fruit, Prevention, risk, vegetable | 3 Comments »
There is a recognized risk for development of secondary primary cancers (SPCs) after first-line treatment with radiation therapy for localized prostate cancer. However, a new article suggests that newer forms of radiation therapy may have noticeably reduced that risk.
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: cancer, outcome, radiation, secondary | 6 Comments »
For the serious student of the biological sciences, the idea that the immediate, internal, biological environment can profoundly impact the ability of any type of cell to grow and evolve is hardly new.
Filed under: Uncategorized | Tagged: cancer, cell, development, environment | Leave a Comment »
As we have suggested before in these reports, the question of whether mass, population-based screening for certain cancers (including prostate cancer) is really the best strategy for prevention of risk from the disease itself is a complex one.
Filed under: Diagnosis, Management, Risk | Tagged: breast, cancer, risk, screening | 4 Comments »
The relative merits of proton beam radiotherapy (PBRT) and the more commonly available intensity-modulated radiotherapy (IMRT) as forms of external beam radiation for prostate cancer are much debated … with minimal supportive evidence on either side of the debate because no comparative trial has ever been carried out.
Filed under: Management, Treatment | Tagged: cancer, IMRT, intensity-modulated, PBRT, proton beam, radiation, second, therapy | 3 Comments »
Some regular readers of the cancer literature may want to see an article just published in the Journal of Clinical Oncology by Leonard Salz, MD (a world-famous colorectal cancer specialist) on the way in which language affects perceptions in the world of cancer communication. The article basically says we all need to be more specific [...]
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: cancer, hope, hype | Leave a Comment »
An article in today’s New York Times, based on an article by Zahl et al. to be published next Tuesday in the Achives of Internal Medicine (but already available on line), is about to stir up a hornets’ nest in the world of cancer research.
Filed under: Diagnosis, Living with Prostate Cancer | Tagged: Add new tag, cancer, remission, spontaneous | 3 Comments »
Search for new and
ongoing trials on the
CTAG PCa web site